Lite Strategy, Inc. Increase (Decrease) in Other Noncurrent Assets
Lite Strategy, Inc. (LITS) reported Increase (Decrease) in Other Noncurrent Assets of $678.00 thousand for the 9-month period ending 2026-03-31, per its 10-Q filed 2026-05-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-05-13
- Lite Strategy, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$27.00K.
- Lite Strategy, Inc. increase (decrease) in other noncurrent assets for the quarter ending 2025-03-31 was $0.00.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month |
|---|---|---|---|
| 2026-03-31 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $678.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $705.00K 10-Q · filed 2026-02-17 | ||
| 2025-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | |
| 2024-12-31 | $0.00 10-Q · filed 2026-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |